Cassey Crowell, DPM
Podiatrist · Richmond, INNPI 1700261872
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (38.2%), food and beverage and education — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Osteomed LLC at 38.2% of the total. Reporting peaked in 2019 at $3,521 and has fallen 90.7% since, to $326 in 2025.
Across 78 payments — averaging $100.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Osteomed LLC$3K
- Trilliant Surgical LLC.$2K
- Stryker$1K
- Celularity Inc.$294
- Kerecis Limited$281
- Johnson & Johnson$235
- plus $703 from 14 others
What the payments were for
- Speaking & faculty fees$3,00038%
- Travel & lodging$5247%
- Food & beverage$2,33030%
- Education$2,00025%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Osteomed LLC | 3 | $3,000 |
| Trilliant Surgical LLC. | 2 | $2,000 |
| Stryker(2 entities) | 14 | $1,341 |
| Celularity Inc. | 3 | $294 |
| Kerecis Limited | 11 | $281 |
| Johnson & Johnson | 7 | $235 |
| Smith+Nephew | 9 | $171 |
| Integra Lifesciences Corporation | 7 | $103 |
| AbbVie | 4 | $95 |
| DJO, LLC | 3 | $67 |
| Bioventus LLC | 3 | $48 |
| Bsn Medical Inc | 2 | $43 |
| Tactile Systems Technology Inc | 3 | $41 |
| Linvatec Corporation | 1 | $28 |
| Mimedx Group, Inc. | 1 | $25 |
| Medline Industries LP | 1 | $24 |
| GRT US Holding, Inc. | 1 | $18 |
| Convatec Inc. | 1 | $16 |
| Osiris Therapeutics Inc. | 1 | $12 |
| Arthrosurface Incorporated | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXT-Large Cannulated$2,000
- EXT-Extremilock Foot$2,000
- EXT-ExtremiLock Ankle$2,000
- EXT-ExtremiFix Midsize/Large$2,000
- Arsenal$2,000
- EXT-Other$1,000
- EXT-Staple$1,000
- EXT-InterPhlex$1,000
- HOFFMANN$655
- Biovance$267
- Interfyl$267
- UltraMist$267
- STAR$122
How this compares
$7,853 in reported general payments places this provider in the 85th percentile of 131 podiatrist providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 146 | $2,951 |
| Gabapentin | 23 | $521 |
| Doxycycline Hyclate | 11 | $70 |
| Cephalexin | 16 | $70 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $29 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Richmond
- Andrew RaderJasper$726K
- Anthony MillerIndianapolis$292K
- Corey GrohIndianapolis$57K
- Jeffrey StevensIndianapolis$56K
- James VestileTipton$44K
- Andrew KapsalisAvon$37K
- Scott HoffmanAvon$22K
- John RachoyMunster$21K
- Townsen KenningtonFort Wayne$20K
- Jared MoonCrown Point$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.